{"disease":{"id":"in-utero-drug-exposure","name":"in utero drug exposure"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04763668","title":"Cardiometabolic Health of Children Exposed to Anti-retroviral Therapy (ART) in Utero","phase":"","overall_status":"UNKNOWN","enrollment_count":320,"lead_sponsor_name":"Walter Sisulu University","has_results":false},{"nct_id":"NCT05766007","title":"Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"University of Liverpool","has_results":false},{"nct_id":"NCT04050189","title":"Validation of the In-utero Transmission of Probiotics","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Centre de recherche du Centre hospitalier universitaire de Sherbrooke","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}